Fecal microbiota transplants have been used to treat various ailments, from obesity to irritable bowel syndrome, to mixed success. Rebyota is a blend of donor stool, saline, and laxative solution given in a single treatment as an enema. FDA granted approval for a feces-based microbial treatment for a C. difficile infection that can become life-threatening. In the US, C. Difficile infections are associated with up to 30,000 deaths per year. The FDA noted that given the variability of fecal matter, there is a potential that it could contain an infectious agent or food allergensens. The approval is an advance in advance of ‘an advance of advance in the advance of Rebyby . . .
[su_button url=’https://arstechnica.com/science/2022/12/prescription-poop-is-here-fda-approves-fecal-slurry-for-unshakeable-diarrhea/’ target=’_blank’ style=’ghost’ background=’#010066′ color=’#010066′ size=’2′ wide=’no’ center=’no’ radius=’auto’]Read more at arstechnica.com[/su_button]




By
By
By
By

By
By
By







